ArticleFrontiers in endocrinology2026
Assessing the association of FIB-4 index with diabetic kidney disease in patients with diabetes mellitus: a cross-sectional and retrospective study utilizing NHANES and clinical data.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate the cross-sectional of the FIB-4 index with the prevalence of diabetic kidney disease (DKD) and the deterioration of renal function in patients with diabetes mellitus (DM). Methods: Data were derived from two cohorts: 1294 patients from the National Health and Nutrition Examination Survey (NHANES) and 692 inpatients from the department of endocrinology of the First Affiliated Hospital of USTC. Logistic regression was used to evaluate the association between the FIB-4 index and the presence of DKD among patients with DM. Results: FIB-4 was identified as an independent risk factor associated with DKD in the clinical inpatient cohort. However, it should be noted that this association was not statistically significant in the weighted NHANES population. Poor control of blood glucose and lipid in DM patients was an important risk factor for disease progression. Effective control of blood glucose and lipid was essential to prevent metabolic diseases. Conclusion: In patients with DM and DKD, attention should be paid to the control of blood glucose and lipid. Especially for DKD patients, and timely monitoring of FIB-4 index may be one of the important strategies to prevent the deterioration of renal function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.